Immune Responses in Severe COVID-19 Patients

WEBINAR

The global patient mortality rate of COVID-19 was 3-4% of confirmed cases in 2020 since the outbreak first began. The response of the immune system may play a critical role in the disease progression, severity, and mortality of COVID-19, with some studies showing decreased T cells and natural killer cells in patients infected with SARS-CoV-2, the virus responsible for COVID-19.

Professor Dexi Chen, the Director of the Beijing Institute of Hepatology, investigated the immune system of patients suffering from severe COVID-19. The study uncovered a decreased proportion of T-cells and downregulation of genes related to T-cell activation and differentiation in severe COVID-19 patients.

This information may help researchers understand the immune response to COVID-19 and inform treatment strategies for the disease.

In this webinar, you will discover:

• How the immune response in severe COVID-19 patients was assessed.
• The change in the T-cell population for patients suffering from severe COVID-19.
• Changes in expression of genes related to T-cell activation and differentiation.
• How this information may help researchers understand the immune response to COVID-19 and inform treatment strategies.

For Research Use Only. Not For Use In Diagnostic Procedures.